Abstract
PMS10 Real-World Characteristics of Ankylosing Spondylitis Patients WHO Started Treatment with Secukinumab: Nationwide Results from the Reuma.PT Registry
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have